Drug Substance Manufacturing Services

End-to-End Drug Substance Manufacturing

Samsung Biologics delivers advanced drug substance manufacturing services with a proven track record and high batch success rates. Our scalable biologics CDMO operations ensure seamless clinical-to-commercial manufacturing while adhering to strict CGMP manufacturing standards. Our bioreactor capacity ranges from 1,000 L to 15,000 L, including both single-use bioreactor manufacturing and stainless steel options, enabling flexible large-scale biologics manufacturing tailored to diverse process requirements. Learn more about our expertise in Biopharma Manufacturing.

Modalities

With extensive experience in next-generation biologics, Samsung Biologics continuously invests in novel modalities and cutting-edge technologies. Our services encompass monoclonal antibody manufacturing, recombinant protein manufacturing, mRNA manufacturing, and ADC manufacturing, ensuring alignment with evolving client needs and regulatory compliance. Our commitment to Quality Assurance and Quality Control maximizes product integrity and client satisfaction.

CGMP Cell Culture Capabilities

Our CGMP manufacturing environment supports diverse cell culture processes and volumes for maximum flexibility. We implement innovative bioprocess technologies such as N-1 perfusion for high cell density and single-use ATF to reduce contamination risk. As a leading mammalian cell culture CDMO, Samsung Biologics optimizes operations for seamless biopharmaceutical production. Our commercial manufacturing suites feature advanced equipment for virus filtration, chromatography, and Grade A bulk filling capacity to meet complex production needs. Partner with us for full lifecycle support including Drug Substance Manufacturing and Process Development.
  • Commercial

    As one of the top biologics CDMO by production capacity, Samsung Biologics specializes in large-scale biologics manufacturing with a focus on commercial mammalian cell culture services. Our advanced production suites are equipped with chrmoatography columns, UF/DF skids, virus filtration skids, product pool vessels, and Grade A bulk filling capability to address complex process demands. With flexible bioreactor sizes, Samsung Biologics collaborates with clients throughout the entire product lifecycle, ensuring efficient and reliable drug substance manufacturing and drug product manufacturing for seamless drug supply management. Discover our Biopharma Manufacturing capabilities.
  • Mid to Late-stage Clinical

    Samsung Biologics offers comprehensive CGMP manufacturing services tailored to mid- to late-stage clinical development. Our versatile bioreactor capacities, state-of-the-art technologies, and deep technical expertise make us a reliable partner for clinical manufacturing and process characterization. We support all pre-BLA activities and provide integrated post-launch lifecycle management, efficiently addressing commercial and CMC requirements. Learn about our Process Development and Analytical Development services designed to accelerate your biologics development timeline.

Facility

Samsung Biologics operates multiple state-of-the-art plants equipped with scalable bioreactors from 1,000 L to 15,000 L, both single-use and stainless steel, to support mid- to late-stage clinical and commercial biologics manufacturing. Our production capacity and technical expertise make us a trusted biologics CDMO partner for clients worldwide.
  • Plant 1
    Plant 1
    30 kL
  • Plant 2
    Plant 2
    154 kL

    *N-1 Perfusion

  • Plant 3
    Plant 3
    180 kL

    *N-1 Perfusion

  • Plant 4
    Plant 4
    240 kL

    *N-1 Perfusion

  • Plant 5
    Plant 5
    180 kL

    *N-1 Perfusion

  • kL
    Total Capacity
  • %
    Batch success rate

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required